Arcus Biosciences (RCUS) EBT Margin Growth (3y) (2020 - 2026)
Arcus Biosciences (RCUS) EBT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,237.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -120.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Arcus Biosciences | 3.57 Bn | 2.75 Bn | - | -44,094.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,094.00 |
| Dec 31, 2025 | -12,415.00 |
| Sep 30, 2025 | -32,226.00 |
| Mar 31, 2025 | -2,778.00 |
| Dec 31, 2024 | -43,708.00 |
| Sep 30, 2024 | 63,251.00 |
| Jun 30, 2024 | 56,452.00 |
| Mar 31, 2024 | 76,453.00 |
| Dec 31, 2023 | -163.00 |
| Sep 30, 2023 | -21,845.00 |
| Jun 30, 2023 | 232,048.00 |
| Mar 31, 2023 | 127,389.00 |
| Dec 31, 2022 | -205.00 |
| Sep 30, 2022 | 105,989.00 |
| Jun 30, 2022 | 133,345.00 |
| Mar 31, 2022 | 61,286.00 |
| Dec 31, 2021 | 281,371.00 |
| Sep 30, 2021 | -57,654.00 |
| Jun 30, 2021 | 36,590.00 |
| Mar 31, 2021 | 25,095.00 |